No Data
No Data
Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
Catalyst Pharmaceuticals Sees FY25 Revenue $545M-$565M, Consensus $558.08M
Catalyst Pharmaceuticals | 8-K: Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Catalyst Pharmaceuticals Reports Record $491.7 Million in Total Revenues for Full Year 2024, Projects Continued Growth for 2025
Catalyst Pharmaceuticals, Inc. Non-GAAP EPS of $0.70 Beats by $0.15, Revenue of $141.8M Beats by $7.6M
Express News | Catalyst Pharmaceuticals Shares up 8% After the Bell Following Results, Outlook